bivalirudin (Sagent Pharmaceuticals)
Welcome to the PulseAid listing for the bivalirudin drug offered from Sagent Pharmaceuticals. This Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sagent Pharmaceuticals |
| NON-PROPRIETARY NAME: | bivalirudin |
| SUBSTANCE NAME: | BIVALIRUDIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-10-01 |
| END MARKETING DATE: | 0000-00-00 |
bivalirudin HUMAN PRESCRIPTION DRUG Details:
| Item Description | bivalirudin from Sagent Pharmaceuticals |
| LABELER NAME: | Sagent Pharmaceuticals |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 250(mg/1) |
| START MARKETING DATE: | 2016-10-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 25021-405_2f5bb80b-2561-483f-afa2-0acaeb30c28d |
| PRODUCT NDC: | 25021-405 |
| APPLICATION NUMBER: | ANDA091602 |
Other BIVALIRUDIN Pharmaceutical Manufacturers / Labelers:
